Tramontozzi C, Riccio A, Pauciullo S, La Frazia S, Rossi A, Santoro M
J Virus Erad. 2024; 10(3):100387.
PMID: 39399815
PMC: 11470169.
DOI: 10.1016/j.jve.2024.100387.
Liu Y, Luo Z
Int J Mol Sci. 2024; 25(13).
PMID: 39000055
PMC: 11240997.
DOI: 10.3390/ijms25136946.
Moshawih S, Jarrar Q, Bahrin A, Lim A, Ming L, Goh H
Heliyon. 2024; 10(3):e25734.
PMID: 38356603
PMC: 10864964.
DOI: 10.1016/j.heliyon.2024.e25734.
Karousis E, Schubert K, Ban N
EMBO J. 2024; 43(2):151-167.
PMID: 38200146
PMC: 10897431.
DOI: 10.1038/s44318-023-00019-8.
Nejat R, Torshizi M, Najafi D
Vaccines (Basel). 2023; 11(2).
PMID: 36851081
PMC: 9968219.
DOI: 10.3390/vaccines11020204.
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases.
Ludwig S, Pleschka S, Planz O
Curr Opin Virol. 2023; 59:101304.
PMID: 36841033
PMC: 10091867.
DOI: 10.1016/j.coviro.2023.101304.
Impairment of antiviral immune response and disruption of cellular functions by SARS-CoV-2 ORF7a and ORF7b.
Garcia-Garcia T, Fernandez-Rodriguez R, Redondo N, de Lucas-Rius A, Zaldivar-Lopez S, Lopez-Ayllon B
iScience. 2022; 25(11):105444.
PMID: 36310646
PMC: 9597514.
DOI: 10.1016/j.isci.2022.105444.
COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity.
Lundstrom K, Hromic-Jahjefendic A, Bilajac E, Aljabali A, Baralic K, Sabri N
Cell Signal. 2022; 101:110495.
PMID: 36252792
PMC: 9568271.
DOI: 10.1016/j.cellsig.2022.110495.
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.
Barbagallo D, Palermo C, Barbagallo C, Battaglia R, Caponnetto A, Spina V
Cell Mol Life Sci. 2022; 79(2):75.
PMID: 35039944
PMC: 8763136.
DOI: 10.1007/s00018-021-04119-8.
The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Schreiber A, Viemann D, Schoning J, Schloer S, Mecate Zambrano A, Brunotte L
Cell Mol Life Sci. 2022; 79(1):65.
PMID: 35013790
PMC: 8747446.
DOI: 10.1007/s00018-021-04085-1.
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target.
Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N
Sci Total Environ. 2021; 808:152072.
PMID: 34863742
PMC: 8634688.
DOI: 10.1016/j.scitotenv.2021.152072.
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
Avolio E, Carrabba M, Milligan R, Kavanagh Williamson M, Beltrami A, Gupta K
Clin Sci (Lond). 2021; 135(24):2667-2689.
PMID: 34807265
PMC: 8674568.
DOI: 10.1042/CS20210735.
Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19.
Zhou B, Li S, Ye J, Liu Y, Hu L, Tang Y
Int Immunopharmacol. 2021; 101(Pt B):108254.
PMID: 34710657
PMC: 8527889.
DOI: 10.1016/j.intimp.2021.108254.
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.
Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A
Mol Syst Biol. 2021; 17(10):e10387.
PMID: 34664389
PMC: 8524328.
DOI: 10.15252/msb.202110387.
Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients.
Abdelhafiz A, Fouad M, Sayed-Ahmed M, Kamel M, Ali A, Fouda M
Virology. 2021; 563:74-81.
PMID: 34478955
PMC: 8397927.
DOI: 10.1016/j.virol.2021.08.012.
Identifying Loci Associated With Bovine Corona Virus Infection and Bovine Respiratory Disease in Dairy and Feedlot Cattle.
Kiser J, Neibergs H
Front Vet Sci. 2021; 8:679074.
PMID: 34409086
PMC: 8364960.
DOI: 10.3389/fvets.2021.679074.
Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection.
Melano I, Kuo L, Lo Y, Sung P, Tien N, Su W
Viruses. 2021; 13(7).
PMID: 34372507
PMC: 8310019.
DOI: 10.3390/v13071301.
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?.
Spinetti G, Avolio E, Madeddu P
Regen Med. 2021; 16(5):477-494.
PMID: 33988482
PMC: 8127835.
DOI: 10.2217/rme-2020-0189.
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.
Jamalkhah M, Asaadi Y, Azangou-Khyavy M, Khanali J, Soleimani M, Kiani J
J Transl Med. 2021; 19(1):164.
PMID: 33888147
PMC: 8061879.
DOI: 10.1186/s12967-021-02840-3.
A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study.
Wang Z, Li K, Maskey A, Huang W, Toutov A, Yang N
FASEB J. 2021; 35(4):e21360.
PMID: 33749932
PMC: 8250068.
DOI: 10.1096/fj.202001792R.